We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Samsung Plans Deeper Expansion into Vaccines and Other Biopharmaceuticals
Samsung Plans Deeper Expansion into Vaccines and Other Biopharmaceuticals
South Korean conglomerate Samsung, which already manufactures Moderna’s COVID-19 vaccine, plans to increase its involvement in the biopharmaceuticals space.